Elsevier

American Heart Journal

Volume 130, Issue 4, October 1995, Pages 734-740
American Heart Journal

Clinical investigation
Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina

https://doi.org/10.1016/0002-8703(95)90071-3Get rights and content

Abstract

Recently developed unstable angina clinical practice guidelines have recommended risk stratification with dipyridamole thallium-201 myocardial imaging in patients at “intermediate” pretest clinical risk who cannot exercise maximally. The prognostic value of predischarge dipyridamole technetium 99m sestamibi (MIBI) tomography has not been assessed in this clinical setting. To this end, 128 medically treated patients with unstable angina at intermediate pretest clinical risk underwent follow-up for 16 ± 11 (mean ± SD) months after predischarge intravenous dipyridamole MIBI tomography. An abnormal MIBI scan result was present in 99 patients (77%), of whom 47 had one or more reversible and 76 had one or more fixed perfusion defects. Cardiac events occurred in 68 (53%) patients after dipyridamole testing: recurrent unstable angina (n = 36), nonfatal acute myocardial infarction (n = 6), or death (n = 26). A cardiac event occurred in 10% of patients with normal MIBI tomography results compared with 69% of those with abnormal results (p < 0.01). Event rates associated with specific perfusion defects were similar (reversible = 68%; fixed = 71%) and were greater than rates in patients without defects (both p < 0.05). Clinical variables associated with increased risk of cardiac events by univariate analysis included a history of congestive heart failure, prior myocardial infarction, and diabetes mellitus (all p < 0.05). Independent multivariable predictors (Cox proportional hazards model) of any cardiac event were an abnormal result of MIBI scan (relative risk [RR] = 4.3, 95% confidence interval [CI] 1.5 to 12.0) and a reversible (RR = 1.8, 95% CI 1.1 to 2.9) or a fixed perfusion defect (RR = 2.9, 95% CI 1.6 to 5.4). Two-year cardiac event-free survival was significantly lower in patients with an abnormal MIBI study result (p < 0.0002). We conclude that the use of predischarge dipyridamole MIBI myocardial tomography provides prognostic information in medically treated patients with unstable angina beyond that available with clinical risk assessment alone. This application of dipyridamole MIBI myocardial imaging is consistent with the recommended use of dipyridamole thallium-201 imaging in published unstable angina clinical practice guidelines.

References (25)

  • TP Rocco et al.

    Comparison of thallium redistribution with rest “reinjection” imaging for the detection of viable myocardium

    Am J Cardiol

    (1990)
  • RJ Luchi et al.

    Comparison of medical and surgical treatment for unstable angina pectoris

    N Engl J Med

    (1987)
  • Cited by (43)

    • Non-ST-Elevation Acute Coronary Syndrome Prognosis

      2017, Encyclopedia of Cardiovascular Research and Medicine
    • Coronary artery calcium scoring in the emergency department: Identifying which patients with chest pain can be safely discharged home

      2010, Annals of Emergency Medicine
      Citation Excerpt :

      With more than 5 million annual hospital admissions, and at a cost of more than $10 billion, most patients (>60%) are found to have noncardiac chest pain.1 Stress tomographic myocardial perfusion imaging (SPECT) can effectively identify these low-risk patients2 but generally requires a prolonged stay in the ED or admission to an observational chest pain unit. To develop an efficient ED-based approach, an accurate, readily available imaging method is needed to rapidly distinguish ischemic from nonischemic conditions, thereby facilitating direct discharge home or appropriate hospital admission.

    • Myocardial metabolic imaging in the acute care setting

      2007, Journal of Nuclear Cardiology
      Citation Excerpt :

      Typically, exercise or pharmacologic stress testing in conjunction with perfusion imaging is used to rule out myocardial ischemia and thereby determine who can be discharged home or admitted for further evaluation. Considerable prognostic data for patients with unstable angina17-21 and for post-AMI patients22-29 have been published, indicating that the presence and extent of stress-induced myocardial ischemia predict subsequent outcome. Recently, the adenosINe Sestamibi SPECT Post-InfaRction Evaluation (INSPIRE) investigators showed in 728 patients that adenosine Tc-99m sestamibi SPECT performed early after hospital admission for AMI with ST-segment elevation and AMI with non–ST-segment elevation could identify a low-risk population accurately where medical therapy and early hospital discharge are appropriate.30,31

    View all citing articles on Scopus
    View full text